Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Larotinib is a multi-kinase inhibitor.1 It inhibits wild-type EGFR (IC50 = 0.6 nM), mutant EGFRs, including EGFRL858R and EGFRL861Q (IC50s = 0.563 and 0.423 nM, respectively), HER2 (IC50 = 253 nM), and HER4 (IC50 = 84 nM). It also inhibits receptor-interacting serine/threonine kinase 2 (RIPK2), IL-1 receptor-associated kinase 1 (IRAK1), B-lymphoid kinase (Blk), and Bruton’s tyrosine kinase (BTK; IC50s = 26.6, 167, 102, and 196 nM, respectively).
WARNING This product is not for human or veterinary use.
1. Phase I trial to evaluate the tolerance, pharmacokinetics and efficacy of the broad-